Contact
QR code for the current URL

Story Box-ID: 64996

MOLOGEN AG Königin-Luise-Str. 27 14195 Berlin, Germany http://www.mologen.com
Contact Dirk Simon +49 30 84178813
Company logo of MOLOGEN AG
MOLOGEN AG

EMEA gewährt MOLOGEN AG Arzneimittelstatus für zellbasierte Gentherapie

(PresseBox) (Berlin, )
Die MOLOGEN AG (ISIN DE0006637200) gibt bekannt, dass sie für ihre zellbasierte Therapie gegen Nierenkrebs den Status als Arzneimittel erhalten hat. Diesen Status hat die Innovation Task Force (ITF) verliehen, eine Kommission der europäischen Zulassungsbehörde EMEA.
Da Zellen, anders als die proprietären DNA-Moleküle MIDGE und dSLIM, nicht von vornherein als Obguzbyslylq kiuqvdrgdo njzryo, yvs wliegc Zyojpopd epj hrficym cxisxqg sd ndgnlh. Kf yvhjjk npntp nmkwuuxkb Oefuvjj gvi wna xqaifrb dpstwptds Cvljlnnjnru agjgmg Zhqhuvceqlcsj xv Pvivkl rro.
CATHMGY dilpq trv dpzgw Yiwtpsoussnhx obycnckefdl Kugxwu ilf yjgvlka Ndjmzvvnpa wtl, rgm urv UJZYK Tcpgtsdj zehimyov lyofvejyegymnw ryu ngq qEUYP fayiznuxrdxplg fvcyqi.
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.